Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Autophagy01:27

Autophagy

5.5K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.5K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

8.6K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.6K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

4.3K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.3K
The Proteasome01:13

The Proteasome

1.4K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.4K
The Proteasome02:18

The Proteasome

9.9K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
9.9K
Autophagic Cell Death01:18

Autophagic Cell Death

4.1K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and validation of survival nomograms in elder triple-negative invasive ductal breast carcinoma patients.

Expert review of anticancer therapy·2024
Same author

Macrophage-Related Gene Signatures for Predicting Prognosis and Immunotherapy of Lung Adenocarcinoma by Machine Learning and Bioinformatics.

Journal of inflammation research·2024
Same author

[The correlation between preoperative neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio and postoperative recurrence of chronic rhinosinusitis].

Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery·2024
Same author

Levitated 2D manipulation on dielectric metasurface by the tuning of polarization states.

Optics letters·2024
Same author

Clinical considerations of CDK4/6 inhibitors in HER2 positive breast cancer.

Frontiers in oncology·2024
Same author

Oxidation of p-toluenesulfonic acid fractionated hybrid Pennisetum by different methods for carboxylated nanocellulose preparation: The evaluation of efficiency and sustainability.

Bioresource technology·2024

Related Experiment Video

Updated: Dec 14, 2025

Assays for the Degradation of Misfolded Proteins in Cells
10:56

Assays for the Degradation of Misfolded Proteins in Cells

Published on: August 28, 2016

12.4K

Autophagy and Polyglutamine Disease.

Haigang Ren1, Zongbing Hao1, Guanghui Wang2

  • 1Laboratory of Molecular Neuropathology, Jiangsu Key Laboratory of Neuropsychiatric Diseases, Department of Pharmacology, College of Pharmaceutical Sciences, Soochow University, Suzhou, 215123, Jiangsu, China.

Advances in Experimental Medicine and Biology
|July 17, 2020
PubMed
Summary

Polyglutamine diseases stem from expanded CAG repeats, leading to neurodegeneration. This study reviews how the ubiquitin-proteasome system and autophagy manage toxic protein buildup in Huntington

Keywords:
AutophagyHuntington’s diseasePolyglutamine diseaseSCA3SCA7

More Related Videos

Growth Assays to Assess Polyglutamine Toxicity in Yeast
09:06

Growth Assays to Assess Polyglutamine Toxicity in Yeast

Published on: March 5, 2012

13.8K
Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity
08:16

Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity

Published on: September 21, 2021

3.8K

Related Experiment Videos

Last Updated: Dec 14, 2025

Assays for the Degradation of Misfolded Proteins in Cells
10:56

Assays for the Degradation of Misfolded Proteins in Cells

Published on: August 28, 2016

12.4K
Growth Assays to Assess Polyglutamine Toxicity in Yeast
09:06

Growth Assays to Assess Polyglutamine Toxicity in Yeast

Published on: March 5, 2012

13.8K
Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity
08:16

Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity

Published on: September 21, 2021

3.8K

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Polyglutamine (polyQ) diseases are fatal neurodegenerative disorders caused by expanded CAG repeats in specific genes.
  • The length of the polyQ fragment correlates with disease onset and severity.
  • Over nine polyQ diseases identified, including Huntington disease (HD) and various spinocerebellar ataxias (SCAs).

Purpose of the Study:

  • To summarize the roles of the ubiquitin-proteasome system (UPS) and autophagy in polyQ disease protein accumulation.
  • To focus on three key polyQ diseases: Spinocerebellar Ataxia type 3 (SCA3), Spinocerebellar Ataxia type 7 (SCA7), and Huntington's disease (HD).

Main Methods:

  • Literature review and synthesis of existing research on protein degradation pathways in polyQ diseases.
  • Comparative analysis of the involvement of UPS and autophagy in SCA3, SCA7, and HD.

Main Results:

  • Autophagy is crucial for clearing disease-related proteins in polyglutamine diseases.
  • The ubiquitin-proteasome system also contributes to the management of toxic polyQ protein fragments.
  • Dysregulation of these systems exacerbates protein aggregation and neurodegeneration.

Conclusions:

  • Understanding the interplay between UPS and autophagy is vital for developing therapeutic strategies for polyQ diseases.
  • Targeting protein degradation pathways offers potential for treating neurodegenerative conditions like HD, SCA3, and SCA7.